Clinical Trial Update: A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial comparing celecoxib 200 mg twice daily to tramadol 50 mg four times daily for chronic low back pain; results available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Celecoxib (Celecoxib)
• Tramadol (tramadol)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2009-11-23